
    
      A pilot (double blind controlled) study randomizing patients to treatment either with
      Ciclosporin or Prednisolone to assess the safety, tolerability and efficacy of Ciclosporin in
      the treatment of patients with new acute Type 2 reactions (ENL).
    
  